Author Reply to the Editor
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Han M, Bach D, Hagan P, Yow E, Flaherty K, Toews G
. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. Chest. 2013; 143(6):1699-1708.
PMC: 3673665.
DOI: 10.1378/chest.12-1594.
View
2.
Barnett C, Bonura E, Nathan S, Ahmad S, Shlobin O, Osei K
. Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience. Chest. 2009; 135(6):1455-1461.
PMC: 2821289.
DOI: 10.1378/chest.08-1881.
View
3.
Hoeper M, Lee S, Voswinckel R, Palazzini M, Jais X, Marinelli A
. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006; 48(12):2546-52.
DOI: 10.1016/j.jacc.2006.07.061.
View
4.
Baughman R, Judson M, Lower E, Highland K, Kwon S, Craft N
. Inhaled iloprost for sarcoidosis associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis. 2010; 26(2):110-20.
View
5.
Milman N, Burton C, Iversen M, Videbaek R, Jensen C, Carlsen J
. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?. J Heart Lung Transplant. 2008; 27(3):329-34.
DOI: 10.1016/j.healun.2007.11.576.
View